News & Updates
Filter by Specialty:
Semaglutide benefits extend to HFpEF patients with T2D
The weight loss and heart failure (HF) benefits of semaglutide extend to patients with obesity-related HF with preserved ejection fraction (HFpEF) and type 2 diabetes (T2D) in the STEP-HFpEF DM trial, fuelling speculation that semaglutide may have cardiovascular effects beyond weight loss.
Semaglutide benefits extend to HFpEF patients with T2D
04 May 2024
Prognosis role of blood urea nitrogen to serum albumin ratio established in IPAH
A higher ratio of blood urea nitrogen to serum albumin is indicative of worse outcomes and disease severity in patients with idiopathic pulmonary arterial hypertension (IPAH), according to a study.
Prognosis role of blood urea nitrogen to serum albumin ratio established in IPAH
03 May 2024
No benefit seen for aspirin in breast cancer
Taking aspirin in the adjuvant setting does not appear to lower the risk of recurrence or improve survival in patients with high-risk nonmetastatic breast cancer, as shown in the results of the phase III Alliance A011502 trial.
No benefit seen for aspirin in breast cancer
03 May 2024
Sexual problems remain a burden in breast cancer patients
Sexual disorders are common among breast cancer patients, and such problems may continue for up to 2 years after the cancer diagnosis, according to a study. Notably, a communication gap regarding sexuality persists between patients and healthcare providers.
Sexual problems remain a burden in breast cancer patients
03 May 2024
Self-administered acupressure relieves pain in probable knee OA
A randomized controlled trial (RCT) among community-dwelling middle-aged and older adults shows that self-administered acupressure (SAA) can relieve knee pain in probable knee osteoarthritis (OA).